Reorganization of myometrial extracellular matrix (ECM) is essential for the uterus to achieve powerful synchronous contractions during labor. Remodeling of the ECM has been implicated in membrane rupture and cervical ripening. Because maternal obesity is associated with both delivery disorders and elevated circulating leptin levels, this study aimed to assess the ability of leptin to interfere with lipopolysaccharide (LPS)-induced myometrial ECM remodeling. Myometrial biopsy samples were obtained from women undergoing cesarean delivery before labor onset. Myometrial explants were incubated for 48 h with LPS and leptin. LPS challenge was associated with a marked decrease in collagen content and in heat shock protein (HSP) 47 expression, reflecting a disruption in collagen synthesis and an increase in matrix metalloproteinase (MMP) 2 and MMP9 activity and in MMP2, MMP9, and MMP13 expression. Leptin prevented an LPS-induced decrease in myometrial collagen content in a concentration-dependent manner. This effect was associated with an increase in HSP47 expression and a decrease in MMP2 and MMP9 activity and expression. These results show that leptin prevents LPS-induced myometrial remodeling through collagen synthesis stimulation and inhibition of MMP2 and MMP9. Our study strengthens the hypothesis that leptin plays a role in the development of obesity-related delivery disorders.
INTRODUCTION
Maternal obesity has been reported to be an independent predictor of dysfunctional labor, with delayed onset of labor, leading to higher rates of postdate pregnancies, labor induction, failed induction, and cesarean deliveries [1] [2] [3] [4] [5] . The increased rate of cesarean deliveries in obese women might be explained not only by cephalopelvic disproportion but also by altered uterine contractility [2, 5] . Indeed, Zhang et al. [2] reported that obesity impaired in vitro the ability of the uterus to contract at delivery.
The mechanisms leading to labor onset remain poorly understood. Several studies, however, have suggested extracellular matrix (ECM) remodeling to be involved in the control of parturition and labor [6] [7] [8] [9] . Reorganization of myometrial ECM is essential for the uterus to achieve powerful synchronous contractions during labor [10] and has been implicated in membrane rupture [8] and cervical ripening [9] . At the end of delivery, it drives postpartum uterine involution, allowing the uterus to return to its prepregnancy state [11] .
ECM remodeling is associated with a synthesis disruption and/or a degradation in collagen I and III, the two major components of myometrial ECM [12] . Collagen synthesis can be studied by assessing the expression of heat shock protein (HSP) 47, a collagen-specific molecular chaperone involved in collagen biosynthesis and/or secretion [13] . In that role, HSP47 expression parallels collagen synthesis in various cell types and tissues, and under collagen-related histopathological conditions such as fibrosis [13] . Additionally, digestion of collagen is under the control of matrix metalloproteinases (MMP) including MMP2 and MMP9, extensively studied because of their wide variety of substrates [14] .
While the onset of labor is associated with the increase in expression of different MMPs in the placenta, the fetal membranes, and amniotic fluid [15] , little is known about the activation and regulation of MMP in the myometrium. Nevertheless, an increase in MMP2 and MMP9 activity and expression has been demonstrated in the myometrium of laboring women compared with that in nonlaboring women [7, 9] . Although MMP13 has been detected in human decidua, amniochorion, and amniotic fluid, its expression in decidual cells decreases throughout pregnancy [16, 17] . In rodents, MMP13 is abundantly expressed after labor, suggesting its involvement in the postpartum involution process [14] .
Our team previously reported that inflammation induced by chorioamnionitis, one of the leading causes of preterm labor, is associated with an intense remodeling of human myometrium involving MMP2 and MMP9 activation [18] . We also validated an in vitro model in which incubation of myometrial explants with lipopolysaccharide (LPS) mimics the effects of chorioamnionitis [18] .
There are good, although preliminary, data suggesting that leptin, the obese gene product, might be involved in obesityrelated delivery disorders [19] . Indeed, Moynihan et al. [20] demonstrated that leptin inhibits in vitro myometrial contractility, and we recently demonstrated that leptin was able to prevent myometrial apoptosis [21] . Leptin is a 16-kDa cytokine-type hormone produced mainly by adipocytes [22] . During pregnancy, the placenta becomes a major source of leptin [23] . Circulating leptin levels increase throughout pregnancy and decline after delivery to return to prepregnancy values [24] . Although leptin levels correlate with prepregnancy body mass index (BMI) at each stage of pregnancy [25] , the rate at which leptin levels increase throughout pregnancy is significantly lower for overweight and obese women than for their normal weight counterparts [24] .
In order to further explore the biologic plausibility explaining delivery disorders observed in obese women, we conducted a study to assess the ability of leptin to interfere with remodeling of the myometrial ECM induced by LPS.
MATERIALS AND METHODS

Drugs and Solutions
Recombinant human leptin (reference: L4146) and LPS (Escherichia coli O55:B5, reference: L2880) were purchased from Sigma-Aldrich (Saint-Louis, MO) and dissolved according to the manufacturer's instructions. MMP2, MMP9, MMP13 antibodies and a pharmacological broad-spectrum inhibitor of MMP (GM6001; inhibition constant [K i ] ¼ 500 and 200 pM for MMP2 and MMP9, respectively) were purchased from Calbiochem (Merck Chemicals, Nottingham, U.K.) and HSP47 antibody from Stressgen (Enzo Life Sciences, Villeurbanne, France). GAPDH and secondary antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The leptin receptor antagonist (LPrA, K i ' 6.10 À7 M) was a gift from the Boston Biomedical Research Institute.
Biological Samples
Myometrial biopsy samples were obtained from women undergoing cesarean section prior to the onset of labor, as previously described [18, 21] 
Stimulation of Myometrial Biopsies
Myometrial biopsy specimens were transferred immediately to sterile Dulbecco modified Eagle medium (DMEM, Invitrogen Gibco) and washed twice in sterile PBS (Lonza). Biopsy specimens were cut into small strips and placed in a well containing 2 ml of DMEM supplemented with antibiotic and antifungal agents on a 24-well plate, as previously described [18, 21] . Strips were incubated at 378C in 5% CO 2 for 48 h in order to allow cytokine levels to return to baseline values. To assess the ability of leptin to oppose LPS-induced remodeling, the myometrial strips were then incubated for an additional 48-h period, either with LPS alone (10 lg/ml) or with a mixture of LPS and leptin (from 10 À10 M to 10 À8 M), in which leptin was added 20 min prior to LPS. Then, to investigate the specificity of the observed effect of leptin, a selective leptin receptor (OB-R) antagonist LPrA [26] (10 À6 M and 10 À5 M) was added to the stimulation medium in the following sequence: LPrA was first put into the medium; 1 h later, leptin was added; and 20 min thereafter, LPS was added. The myometrial strips were incubated with this mixture for 48 h. Finally, in a third set of experiments aimed to assess the implication of MMP in LPSinduced remodeling, biopsy specimens were stimulated for 48 h, with LPS (10 lg/ml) alone or with GM6001 (10 À5 M) added to the medium 1 h prior to LPS stimulation [27] .
For each experiment, time-matched vehicle controls were established. At the end of the stimulation period, the supernatant samples and tissues were either quickly frozen in liquid nitrogen and stored at À808C or fixed with 4% paraformaldehyde.
Immunohistochemical Analysis
Myometrial strips were embedded in paraffin and cut into 5-lm-thick sections. After strips were deparaffinized and rehydrated, antigen retrieval was performed for MMP9 and MMP13 by incubating the slides for 10 min in warm citric acid. After endogenous peroxidase activity had been blocked with 3% hydrogen peroxide, nonspecific binding sites were blocked for 30 min with 3% BSA in PBS. Slides were incubated overnight with either a primary anti-MMP2 (1/100 dilution), anti-MMP9 (1/50 dilution) or anti-MMP13 (1/50 dilution) antibody, washed three times with PBS, and incubated with a biotinylated antimouse antibody (1/250 dilution) for 1 h. After washing, the slides were incubated with peroxidase-labeled streptavidin (1/500 dilution) for 30 min and finally with 3-amino-9-ethyl-carbazole solution until a clearly visible color had developed. The reaction was stopped by thorough washing in water. Subsequently, the slides were counterstained with hematoxylin. Negative controls were carried out by omitting the primary antibody.
Sirius Red Staining
Myometrial strips were embedded in paraffin and cut into 5-lm-thick sections. After deparaffinization and rehydration, the sections were incubated with hematoxylin for 2 min, stained in Sirius Red (0.1%; Biocolor, Carrickfergus, U.K.) in saturated picric acid for 30 min, and subsequently washed with distilled water. The slides were examined through polarized light at 3100 magnification, and collagen appeared as bright orange-red and/or bright green, as previously described [28] .
Total Collagen Quantification
Total collagen content was determined using the Sirius Red Sircol assay according to the manufacturer's protocol. Briefly, myometrial explants were diced into small pieces, homogenized in 0.5 M acetic acid containing pepsin (1 mg/10 mg tissue; Sigma-Aldrich), and incubated overnight at 48C with continuous shaking. After digestion, samples were centrifuged, and 100 ll of the supernatant was incubated with 1 ml of Sircol dye reagent for 30 min at room temperature. After centrifugation, the supernatant was discarded, and the precipitated pellet was resuspended in 1 ml of alkali reagent (0.5 M NaOH). Collagen concentration was then determined by spectrophotometric absorbance at 540 nm compared with a standard curve.
Western Blotting Analysis
Snap-frozen myometrial tissues were crushed in liquid nitrogen, homogenized in a lysis buffer, and kept on ice for 30 min, as previously described [26] . After centrifugation at 10 000g for 15 min at 48C, total protein supernatant content was determined using the Bradford assay, with BSA as the standard. Samples (20-40 lg of protein per lane) were dissolved in 23 Laemmli buffer and boiled for 5 min. The proteins were subjected to 10% SDS-PAGE and then transferred to a polyvinylidene fluoride membrane. To block nonspecific antibody binding sites, membranes were incubated for 1 h in 5% non-fat dried milk powder in Tris-buffered saline-Tween 20 (TBST) solution at room temperature. Membranes were washed three times with TBST. The blots were then incubated for 1 h with a dilution of primary mouse anti-MMP2 (1/500 dilution), anti-MMP9 (1/500 dilution), and anti-MMP13 (1/500 dilution) or anti-HSP47 (1/1000 dilution) antibody and in 1% non-fat dried milk powder in TBST. After three washes with TBST, the blots were incubated with horseradish peroxidase-conjugated anti-mouse antibody at a dilution of 1/ 10 000 for 1 h at room temperature and washed three times. Immunoreactive proteins were detected by chemiluminescence. The intensities of the bands were analyzed densitometrically using Image Lab software. The blots were stripped and reprobed with GAPDH antibody and then used as protein loading controls. Results are expressed as means 6 SEM in arbitrary density units (ADU).
Zymography Analysis
The proteolytic activity of MMP2 and MMP9 secreted into the culture medium was assessed by gelatin zymography. A culture medium corresponding WENDREMAIRE ET AL.
to 0.5 mg of tissue was mixed with zymogram buffer (23), loaded, and subjected to electrophoresis on a 10% SDS gel incorporating 3 mg/ml of gelatin. The gels were soaked in renaturing buffer (2.5% Triton X-100) for 30 min, washed with distilled water, and incubated overnight in an activation buffer (50 mM Tris-HCl, pH 8, 10 mM CaCl 2 , 150 mM NaCl). The gels were stained with Coomassie blue in 40% methanol and 10% acetic acid for 1 h at room temperature, and finally destained in 40% methanol and 10% acetic acid. Clear bands on a blue background indicate the presence of gelatin-degrading proteinases. The gelatinolytic activities of MMP2 and MMP9 were estimated by scanning the gels with a densitometer and analyzing the data with Image Lab software. Results are expressed as means 6 SEM in ADU.
Statistical Analysis
Differences between groups were determined by ANOVA followed by Bonferroni or Dunn multiple comparison tests. Statistical analysis was carried out using Instat version 3 software (GraphPad Software, San Diego, CA). All differences were considered significant at a P value of ,0.05.
RESULTS
Patients' Characteristics
Thirty-three women were included in the study. Maternal characteristics are summarized in Table 1 . Figure 1 , A-F, shows the collagen content, revealed by Sirius Red staining, of myometrial samples from 6 different women. Compared with vehicle-treated control condition (Fig.  1A) , LPS stimulation (Fig. 1B) was associated with an apparent decrease in total collagen, indicating ECM remodeling. This decrease preferentially involved large (bright yellow or orange) rather than the thinner or reticular (green) collagen fibers. As shown in Figure 1 , C-E, this decrease in collagen content was prevented by leptin in a concentration-dependent manner, indicating that leptin had an inhibitory effect on myometrial ECM remodeling induced by LPS. Total collagen quantification by Sircol assay (Fig. 1G ) confirmed the effect shown by Sirius Red staining and revealed that leptin effect 
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reached statistical signification at a concentration of 10 À8 M. The preventive effect of leptin on LPS-induced decrease in total collagen content was antagonized by the use of selective OB-R antagonist LPrA at a concentration of 10 À5 M (Fig. 1 , F and G).
Leptin Effects on Myometrial Collagen Synthesis
Western blotting experiments ( Fig. 2A) and densitometric immunoblot analysis (Fig. 2B) revealed that LPS induced a decrease in HSP47 expression that was prevented by leptin at a concentration of 10 À8 M. Furthermore, Figure 2 , C and D, shows that this effect of leptin was abolished in the presence of LPrA at 10 À5 M. As HSP47 is a collagen-specific chaperone, these results indicate that leptin opposes LPS-induced disruption of collagen synthesis.
Leptin Effects on Myometrial Collagen Degradation and MMP Activation and Expression
As a prerequisite for study of the leptin effect on MMP activation and expression, we had to confirm the implication of MMP in LPS-induced ECM remodeling in human pregnant myometrium. Figure 3 shows that MMP2 (Fig. 3, A and B) , MMP9 (Fig. 3, C and D) and MMP13 (Fig. 3 , E and F) are expressed in pregnant myometrium. This staining was specifically located in myometrial cells and was not observed in negative control experiments (Fig. 3, G and H) . Figure 3 suggests that LPS stimulation (upper vs. lower rows) had no effect on MMP distribution within the tissue. Nevertheless, LPS-induced activation of MMP cannot be assessed using this approach as the antibodies recognize both the inactive and active forms. Figure 4 shows the collagen content revealed by Sirius Red staining (Fig. 4 , A-C) and Sircol assay quantification (Fig. 4D ) of myometrial samples from 6 different women. As shown in Figure 4 , C and D, pretreatment of samples with GM6001 (10 À5 M) antagonized the effect of LPS on total collagen content. Compared with the vehicle-treated control condition, LPS stimulation induced an increase in both MMP2 and MMP9 activity that was significantly antagonized by GM6001 (Fig. 4, E and F) . Taken together, these results strongly suggest that activation of MMP2 and MMP9 is involved in LPSinduced myometrial remodeling.
Representative analysis (Fig. 5A ) and semiquantification (Fig. 5 , B and C) of MMP2 and MMP9 activity show that LPS stimulation was associated with an increase in proteolytic activity, which was reversed by leptin. Similarly, Figure 5 , D- WENDREMAIRE ET AL.
F, shows that LPS stimulation was also associated with an increase in MMP2 and MMP9 expression, both of which were reversed by leptin. The effects of leptin on MMP2 activity and expression were significant from the lowest concentration used of 10 À10 M (Fig. 5, C and F) , whereas leptin antagonized MMP9 activity and expression only at the highest concentration used of 10 À8 M (Fig. 5, B and E). In contrast, leptin was not able to antagonize the slight LPS-induced increase in MMP13 expression (Fig. 5, D and G) . Furthermore, Figure 6 , A and D, shows that the effects of leptin on MMP2 and MMP9 activity and expression, respectively, were abolished in the presence of LPrA. Semiquantification revealed that the antagonist effects of LPrA reached statistical significance at a concentration of 10 À6 M for MMP9 activity and 10 À5 M for MMP2 activity, and MMP2 and MMP9 expression (Fig. 6 , B and C and E and F). Figure 7 represents the effect (as percentages) of leptin and LPS stimulation on total collagen content on myometrial tissues obtained from normal weight and obese patients. Compared to tissues from normal weight women (n ¼ 3), the effect of leptin stimulation on total collagen content (whatever the concentration used) seemed less pronounced on tissues from obese women (n ¼ 2), suggesting a resistance to leptin. The small number of tissues precluded any statistical analysis. Furthermore, the effect of LPS stimulation on collagen content appeared to be smaller in tissue samples obtained from obese than those from normal weight women (37% vs. 58.8%, respectively). Similar apparent trends were noticed for MMP2 expression and MMP2 and MMP9 activity (data not shown).
Stimulation Response of Tissues According to Prepregnancy BMI Patients
DISCUSSION
Because obese women exhibit elevated circulating leptin levels [29] , we speculated that delivery disorders observed in these women are linked to the deleterious effects of leptin on labor-associated processes such as myometrial remodeling [7, 15, 19] . The key finding of this work is that leptin is able to oppose LPS-induced remodeling of the myometrial ECM by two mechanisms. First, leptin reversed the decrease in HSP47 expression, reflecting collagen synthesis. Second, leptin reversed the increase in both MMP2 and MMP9 activity and protein overexpression, which in turn prevented the depletion of the myometrial collagen content. Additionally, the present study confirmed the implication of MMP activation in LPSinduced myometrial ECM remodeling.
Our study shows that leptin opposes the decrease in total collagen content induced by LPS. This effect appears to be due first, at least partly, to action on collagen synthesis, reflected by HSP47 expression. The effect of leptin on collagen synthesis has been studied in various tissues (mostly cardiac and hepatic tissues) [30] [31] [32] . In murine hepatic cells, leptin augments profibrogenic responses induced by hepatotoxic chemicals [30] . Used alone, leptin has been demonstrated to induce collagen I gene expression and enhance its protein expression in human hepatic cells [31] . Moreover, a recent study suggested the profibrotic effect of leptin of cardiac ECM through the predominance of collagen synthesis over degradation [32] .
Second, leptin appears to prevent collagen degradation via MMP activation. Our findings of an inhibitory effect of leptin on MMP activation and expression seem to contradict those of other works suggesting that leptin had either no effect or a stimulatory effect on MMP activity or expression [33] [34] [35] [36] [37] [38] . For example, Quinton et al. [33] found no effect of leptin on MMP2 and MMP9 expression in endometrial cells. These LEPTIN AND HUMAN MYOMETRIAL REMODELING apparent discrepancies might be explained by the different cell types assessed (endometrial vs. myometrial) and the pregnancy status with associated hormonal changes (nonpregnant vs. pregnant). In contrast to our results, leptin was reported to increase MMP2 expression and activity in human cardiomyocytes [36] and cultured cytotrophoblasts and MMP9 activity in cytotrophoblasts [34] , suggesting a stimulating effect of leptin on ECM remodeling of some tissues. We have no formal explanation for this discrepancy, but we assume that it also relates to the cell or tissue experimental model and/or with differential functions of leptin in early and late pregnancy. The cytotrophoblasts used by Castellucci et al. [34] were isolated and cultured from trophoblastic tissues obtained from legal abortions performed between 7 and 12 weeks of gestation, whereas our myometrial samples were obtained at the end of pregnancy. This time-related variation in the way leptin regulates the MMP system is supported by a study which showed that leptin stimulated mouse trophoblast invasion on day 10 but not on day 18 of gestation, suggesting that leptin had one or several different functions in these cells during late pregnancy [39] . The underlying mechanism for this differential function of leptin might relate to variations in the expression of leptin receptor isoforms throughout pregnancy. In support of this hypothesis, it has been shown that expression of the long isoform of the receptor in rat placenta remained constant, while that of the short isoform increased from early to late gestation [40] . Unfortunately, the expression of leptin receptor isoforms in pregnant human myometrium has not been yet described.
In contrast to the above, there are few studies reporting, as we do here, an inhibitory effect of leptin on MMP expression [32, 41] . Cao et al. [41] showed that leptin reduces MMP1 gene and protein expression in human hepatic cells. In this study, ERK1/2 activation was found to be implicated in leptin repression on the MMP1 gene by inhibiting MMP1 promoter activity [41] . This is in keeping with our previous study in which we reported that leptin was able to activate the ERK1/2 signaling pathway in myometrial samples [21] . Taken together, our results obtained in both studies suggest, although not formally, that leptin could WENDREMAIRE ET AL.
inhibit MMP2 and MMP9 activity and expression by exerting repressive action on MMP2 and MMP9 genes, through ERK1/2 activation. This hypothesis is supported by a study conducted on lung carcinoma cells, which demonstrated that MMP2 expression was down-regulated via the ERK1/2 signaling pathway induced by insulin growth factor-1 [42] .
In addition, the present study showed that leptin was unable to reverse LPS-induced MMP13 overexpression. Our findings LEPTIN AND HUMAN MYOMETRIAL REMODELING disagree with those of two studies which reported that leptin induced MMP13, but not MMP2 and MMP9 expression in chondrocytes and glioma [37, 38] . These discrepancies might be tissue-dependent or linked to a difference in the signaling pathways involved in MMP activation. Although MMP13 has been detected in human decidua, fetal membranes and amniotic fluid and in rat uterus [16, 17, 43] , few studies have documented the expression and role of MMP13 during labor. Anacker et al. [16] reported that MMP13 expression in human decidual cells was down-regulated during the course of pregnancy. Additionally, MMP13 mRNA levels were low in uterine samples from virgin and pregnant rats but increased transiently by 30-fold postpartum, reaching a maximum on the second day postpartum [43] . Taken together, these data suggest that MMP13 is involved in the postpartum involution process.
Despite the small number of samples, we analyzed the effect of both leptin and LPS stimulation according to maternal prepregnancy BMI. It suggests, although without any statistical assessment, that obesity is associated with an impaired myometrial response to leptin, in favor of peripheral leptin resistance. Indeed, the elevated circulating and tissue leptin levels observed in obese patients [44, 45] might result in an exaggerated stimulation of the tissues leading to the development of a resistance towards leptin action [46] . On the other hand, the lower capability of myometrial samples obtained WENDREMAIRE ET AL.
from pregnant obese women to respond to an inflammatory (LPS) stimulation may result from the mild but chronic inflammation observed in obese patients [47] .
As most of our myometrial samples (25 of 33) were obtained from term women, we have not been able to assess the effect of term on the leptin effect. This is a minor weakness of our study for two reasons. First, obesity has been associated mostly with late pregnancy and delivery disorders; second, whereas pregnancy is associated with some kind of leptin resistance, as is the case with obesity, to ensure sufficient weight gain for the maintenance of pregnancy, this resistance appears to be established at midpregnancy [48, 49] , so it is before our sampling of tissues.
Interestingly, our study confirmed the specificity of MMP activation on LPS-induced myometrial remodeling, as it was prevented by GM6001, a broad-spectrum MMP inhibitor. These results strengthen our previous results, which showed that LPS stimulation of myometrial samples obtained from uncomplicated pregnancies was associated with the same decrease in total collagen and overexpression of MMP2 and MMP9 as that observed in myometrial samples obtained from women with chorioamnionitis [18] . Our findings provide strong support for and expand on those of Koscica et al. [50] , who showed in a mouse model of LPS-induced preterm delivery that intraperitoneal administration of GM6001 decreased the likelihood of inflammation-mediated preterm delivery.
One limitation of our study is that we did not assess the effects of leptin on remodeling in myometrial samples obtained from laboring and nonlaboring women to validate our hypothesis. However, because of ethical considerations, we did not have access to myometrial samples from women already in labor, as in this case, cesarean deliveries are usually performed in an emergency context.
In conclusion, we have demonstrated that leptin was able to prevent myometrial ECM remodeling induced by LPS stimulation and confirmed the implication of MMP activation in this remodeling. Taken together, these data strengthen the hypothesis that leptin plays a role in the development of obesity-related delivery disorders. The underlying mechanisms might involve the inhibition of myometrial contractions [20] , apoptosis [21] , and remodeling, as suggested in the present study. From a clinical point of view, we suggest that elevated leptin levels in obese pregnant women might disrupt the physiological changes involved in delivery [19] . Understanding the pathophysiological mechanisms of these disorders seems essential in order to establish specific obstetric management strategies for these women.
